High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system (Q39127318)
Jump to navigation
Jump to search
scientific article published on 21 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system |
scientific article published on 21 June 2013 |
Statements
1 reference
High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system (English)
1 reference
Katherine H Kim
1 reference
Charlotte Dodsworth
1 reference
Andrea Paras
1 reference
Barbara K Burton
1 reference
21 June 2013
1 reference
1 reference
109
1 reference
4
1 reference
382-385
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference